Buprenorphine Hydrochloride
C29H41NO4·HCl
504.11
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-, hydrochloride, [5α,7α(S)]-;
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride;
(S)-2-[17-(Cyclopropylmethyl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethanomorphinan-7α-yl]- 3,3-dimethylbutan-2-ol hydrochloride [53152-21-9]
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-, hydrochloride, [5α,7α(S)]-;
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride;
(S)-2-[17-(Cyclopropylmethyl)-4,5α-epoxy-3-hydroxy-6-methoxy-6α,14-ethanomorphinan-7α-yl]- 3,3-dimethylbutan-2-ol hydrochloride [53152-21-9]
DEFINITION
Buprenorphine Hydrochloride contains NLT 98.0% and NMT 102.0% of buprenorphine hydrochloride (C29H41NO4·HCl), calculated on the anhydrous and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Buprenorphine Hydrochloride RSUSP Buprenorphine Related Compound A RS
USP Buprenorphine System Suitability Mixture RS